Tampa, FL, United States
Tampa, FL, United States

Health Integrated is an American health care management company based in Tampa, FL, that addresses health, productivity and cost challenges by integrating behavioral health and behavior change into medical and diseasemanagement activities. Health Integrated works with commercial health plans and employers serving more than 5 million members. Wikipedia.

SEARCH FILTERS
Time filter
Source Type

Patent
Health Integrated | Date: 2015-06-29

A control system for controlling one or more of a plurality of exercise apparatuses across a network comprises a processor; a communication subsystem configured to communication with the plurality of exercise apparatuses across the network; and memory for storing information about one or more users. The information comprises, for each user, identity information, including a user identifier; and a resistance level indicator. Upon receipt of a user identifier from an exercise apparatus in the network, the processor is configured to identify the resistance level indicator stored in the memory corresponding to the user identifier, and cause the communication subsystem to transmit to the exercise apparatus the resistance level indicator for that user. Upon receipt of a performance parameter of a user from an exercise apparatus in the network, the processor is configured to determine whether or not to modify the resistance level indicator of that user stored in the memory based on the received performance parameter.


LONG BEACH, Calif.--(BUSINESS WIRE)--Molina Healthcare, Inc. (NYSE: MOH) today announced that its wholly owned subsidiary, Molina Healthcare of Washington, Inc., has been selected by the Washington State Health Care Authority (HCA) to negotiate and enter into managed care contracts for the North Central region of the state’s Apple Health Integrated Managed Care Program. The new contracts will allow only selected Managed Care Organizations (MCOs) to provide the full continuum of behavioral and physical health services that are available to beneficiaries for the entire regional service area. Molina currently provides Medicaid physical health services throughout Washington State, including to beneficiaries in Chelan, Douglas and Grant counties composing the North Central region. Beginning in April 2016, Molina was one of only two MCOs selected by the state HCA to provide fully integrated behavioral and physical health services through the Fully Integrated Managed Care Program in the Southwest region of Washington. Molina Healthcare of Washington was selected by HCA for the state’s north central region pursuant to the request for proposal it issued in February 2017. The start date for the new contract is scheduled for January 1, 2018. “Molina is honored to be selected as one of the plans that will offer coordinated and fully integrated behavioral and physical health care to members in Chelan, Douglas and Grant counties,” said Peter Adler, president of Molina Healthcare of Washington. “We’ve already seen significant benefits providing ‘whole-person care’ under the Fully Integrated Managed Care program in the Southwest region, and we look forward to building on that success with the addition of the North Central region.” The new Apple Health Integrated Managed Care program combines physical and behavioral health services and will include a separate contract for behavioral health wraparound services, which has not traditionally been covered under Medicaid managed care. Since 2000, Molina Healthcare of Washington’s mission has been to provide high quality health care to people receiving government assistance. As of March 2017, the organization serves approximately 785,000 members through Medicaid, Medicare and the Health Benefit Exchange programs across the state of Washington. Additionally, Molina Healthcare operates Molina Medical, a primary care clinic in Everett. Molina Healthcare, Inc., a FORTUNE 500 company, provides managed health care services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through our locally operated health plans in 12 states across the nation and in the Commonwealth of Puerto Rico, Molina serves approximately 4.8 million members. Dr. C. David Molina founded our company in 1980 as a provider organization serving low-income families in Southern California. Today, we continue his mission of providing high quality and cost-effective health care to those who need it most. For more information about Molina Healthcare, please visit our website at molinahealthcare.com. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release contains “forward-looking statements” regarding the selection of Molina Healthcare of Washington to negotiate and enter into managed care contracts for the North Central region of the state’s Apple Health Integrated Managed Care Program. All forward-looking statements are based on current expectations that are subject to numerous risk factors that could cause actual results to differ materially. Such risk factors include, without limitation, a failure of the parties to finalize and execute the new contracts, a delay in the start date for the new contracts, a reversal of the contract awards in connection with a successful protest by another bidder, and results and performance issues under the new contracts that are materially less favorable than those under the existing contracts. Additional information regarding the risk factors to which we are subject is provided in greater detail in our periodic reports and filings with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K. These reports can be accessed under the investor relations tab of our website or on the SEC’s website at sec.gov. Given these risks and uncertainties, we cannot give assurances that our forward-looking statements will prove to be accurate, or that any other results or events projected or contemplated by our forward-looking statements will in fact occur, and we caution investors not to place undue reliance on these statements. All forward-looking statements in this release represent our judgment as of the date hereof, and we disclaim any obligation to update any forward-looking statements to conform the statement to actual results or changes in our expectations that occur after the date of this release.


Patent
Health Integrated | Date: 2017-05-10

A control system for controlling one or more of a plurality of exercise apparatuses across a network comprises a processor;a communication subsystem configured to communication with the plurality of exercise apparatuses across the network; and memory for storing information about one or more users. The information comprises, for each user, identity information,including a user identifier; and a resistance level indicator. Upon receipt of a user identifier from an exercise apparatus in the network, the processor is configured to identify the resistance level indicator stored in the memory corresponding to the user identifier, and cause the communication subsystem to transmit to the exercise apparatus the resistance level indicator for that user. Upon receipt of a performance parameter of a user from an exercise apparatus in the network, the processor is configured to determine whether or not to modify the resistance level indicator of that user stored in the memory based on the received performance parameter.


Younossi Z.,Inova Fairfax Hospital | Henry L.,Health Integrated
Alimentary Pharmacology and Therapeutics | Year: 2015

Background Treatment for chronic hepatitis C (CH-C) is rapidly changing and moving away from an interferon and ribavirin-based therapy to interferon-free ribavirin-free all oral regimens. These regimens are simpler and shorter to administer with very high efficacy rates and better side effect profiles. As advances in the treatment of CH-C occur, it is imperative to capture both clinical outcomes (efficacy and safety) as well as patient-reported outcomes (PROs). In fact, PROs assesses and quantifies the impact of these regimens on patient experience. PROs assess patients' health-related quality of life (HRQOL) especially in the realms of fatigue and neuropsychiatric issues such as depression which can affect treatment adherence and work productivity. Aim To review the literature related to PRO's in HCV patients and summarise the impact of CH-C and its treatment on PROs. Methods Databases Ovid MEDLINE and PubMed were searched from 1990 to October 2014 using a combination of MEsh, thesaurus terms and relevant text words: hepatitis C, CH-C, treatment, quality of life, health-related quality of life, fatigue, work productivity, adherence, patient-reported outcomes, direct acting anti-viral agents and second generation direct acting anti-viral agents. Each manuscript was assessed for pertinence to the issue of PROs in CH-C as well as the quality of study design and publications. Results From the literature, it is evident that CH-C patients have baseline PRO impairment. Furthermore, treatment with interferon with or without ribavirin and first generation DAAs causes additional PRO burden which can negatively impact treatment adherence and indirectly, treatment efficacy and work productivity. The new treatment regimens with interferon- and ribavirin-free regimens not only have very high efficacy, but also result in the improvement of PRO scores as early as 2 weeks into treatment as well as possibly better adherence to treatment regimens. Conclusions CH-C and its treatment have been associated with patient-reported outcome impairment. The new IF-free and RBV-free regimens are associated with high efficacy and substantial improvement of patient-reported outcomes in clinical trial setting. Although very encouraging, more data are needed to assess patient-reported outcomes, adherence and work productivity of CH-C patients in the real world setting of clinical practice. © 2015 John Wiley & Sons Ltd.


To assess whether any benefits from adjunctive homeopathic intervention in patients with RA are due to the homeopathic consultation, homeopathic remedies or both. Exploratory double-blind, randomized placebo-controlled trial conducted from January 2008 to July 2008, in patients with active stable RA receiving conventional therapy. Eighty-three participants from three secondary care UK outpatient clinics were randomized to 24 weeks of treatment with either homeopathic consultation (further randomized to individualized homeopathy, complex homeopathy or placebo) or non-homeopathic consultation (further randomized to complex homeopathy or placebo). Co-primary outcomes: ACR 20% improvement (ACR20) criteria and patient monthly global assessment (GA). Secondary outcomes: 28-joint DAS (DAS-28), tender and swollen joint count, disease severity, pain, weekly patient and physician GA and pain, and inflammatory markers. Fifty-six completed treatment phase. No significant differences were observed for either primary outcome. There was no clear effect due to remedy type. Receiving a homeopathic consultation significantly improved DAS-28 [mean difference 0.623; 95% CI 0.1860, 1.060; P = 0.005; effect size (ES) 0.70], swollen joint count (mean difference 3.04; 95% CI 1.055, 5.030; P = 0.003; ES 0.83), current pain (mean difference 9.12; 95% CI 0.521, 17.718; P = 0.038; ES 0.48), weekly pain (mean difference 6.017; 95% CI 0.140, 11.894; P = 0.045; ES 0.30), weekly patient GA (mean difference 6.260; 95% CI 0.411, 12.169; P = 0.036; ES 0.31) and negative mood (mean difference - 4.497; 95% CI -8.071, -0.923; P = 0.015; ES 0.90). Homeopathic consultations but not homeopathic remedies are associated with clinically relevant benefits for patients with active but relatively stable RA. Current controlled trials, http://www.controlled-trials.com/, ISRCTN09712705.


Johnson C.E.,Health Integrated
Journal of Sexual Medicine | Year: 2011

Introduction. Pregnancy and childbirth is a special period in a woman's life, which involves significant physical, hormonal, psychological, social, and cultural changes that may influence her own sexuality as well as the health of a couple's sexual relationship. Aim. To comprehensively review the literature on the effects of pregnancy and the postpartum period on a couple's sexual health and well-being. Main Outcome Measures. Evidence from the published literature of the impact of pregnancy, childbirth, and the postpartum period on sexual function. Methods. Medline and PubMed search for relevant publications on the effects of pregnancy and childbirth on sexual health and function, with particular focus on the physical, hormonal, psychological, social, and cultural changes that may occur during the antepartum, intrapartum, and postpartum period. Results. Despite fears and myths about sexual activity during pregnancy, maintaining a couple's sexual interactions throughout pregnancy and the postpartum period can promote sexual health and well-being and a greater depth of intimacy. Conclusions. Clinicians must seek to engage in an open discussion and provide anticipatory guidance for the couple on expected changes in sexual health as well as promote the design of rigorous, evidence-based studies to further elucidate our understanding of sexual function during pregnancy and the postpartum. © 2011 International Society for Sexual Medicine.


Cauley L.S.,Health Integrated | Lefrancois L.,Health Integrated
Mucosal Immunology | Year: 2013

Mucosal tissues are continually bombarded with infectious agents seeking to gain entry into the body. The absence of a tough physical exterior layer surrounding these tissues creates a unique challenge for the immune system, which manages to provide broad protection against a plethora of different organisms with the aid of special adaptations that augment immunity at these vulnerable sites. For example, specialized populations of memory T lymphocytes reside at initial sites of pathogen entry into the body, where they provide an important protective barrier. Similar anatomically-confined populations of pathogen-specific CD8 T cells can be found near the outer margins of the body following recovery from a variety of local infections, where they share very similar phenotypic characteristics. How these tissue-resident T cells are retained in a single anatomic location where they can promote immunity is beginning to be defined. Here, we will review current knowledge of the mechanisms that help establish and maintain these regional lymphocytes in the mucosal tissues and discuss relevant data that enhance our understanding of the contribution of these lymphocyte populations to protective immunity against infectious diseases. © 2013 Society for Mucosal Immunology.


An traditional-diagnosis-bypassing method for improving a mental health patient-therapy program through incorporating in it, centrally, a patients expressed therapy goals, including (a) accessing an electronic information system which is programmed with information-capturing and related-question-based, guiding software associated with patient-personalizing therapy planning, structuring and implementing, (b) encouraging a collaboration dialogue between patient and professional to capture information relating to the patients mental health symptoms and associated, patient-expressed therapy goals, and collaboratively entering related dialogue information into the system, and (c) based upon such information entering, and through professional-and-patient interactive engagement with the system, and functioning expressly in a conventional-diagnosis-bypassing, question and answer mode which is bottomed centrally upon recognizing the patients expressed therapy goals, collaboratively designing, building, and thereafter implementing, a patient-specific therapy.


Patent
Health Integrated | Date: 2013-03-12

The present invention provides blood based methods for predicting risk of acute coronary syndrome in a subject.


News Article | February 22, 2017
Site: www.prnewswire.com

PHOENIX, Feb. 22, 2017 /PRNewswire/ -- The Maricopa County Special Health Care District Board of Directors today took an important step in construction of our community's new public teaching hospital and safety net health care system by unanimously approving the company that will oversee...

Loading Health Integrated collaborators
Loading Health Integrated collaborators